<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02151942</url>
  </required_header>
  <id_info>
    <org_study_id>PRS-001</org_study_id>
    <nct_id>NCT02151942</nct_id>
  </id_info>
  <brief_title>Patient-Specific Simulation Used for EVAR Procedure Rehearsal - Evaluation of Clinical Performance With and Without Prior Rehearsal</brief_title>
  <acronym>PRS</acronym>
  <official_title>Patient-Specific Simulation Used for Case Rehearsal Prior to EVAR Procedure - Evaluation of Clinical Performance With and Without Prior Rehearsal Using the Procedure Rehearsal Studio. Multi-center Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Simbionix US Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Simbionix US Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the procedural and clinical benefits of patient
      specific pre-procedure rehearsal for operators with various experience levels as a tool for
      optimizing Endovascular Aneurysm Repair (EVAR) procedures.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Fluoro time</measure>
    <time_frame>Within 4 hr. after EVAR procedure starts</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective operator perceived effectiveness of prior procedure rehearsal</measure>
    <time_frame>Within 4 hr. after EVAR procedure starts</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraprocedural safety measurements</measure>
    <time_frame>Within 4 hr. after EVAR procedure starts</time_frame>
    <description>Overall contrast use (volume)
Skin entry radiation dose
Overall procedure time (from gaining bilateral access until the satisfactory completion of endograft deployment, excluding all adjunctive procedures such as hypogastric embolization, Iliac Percutaneous Transluminal Angioplasty (PTA)/Stenting, sheath removal and hemostasis time)
Procedural blood loss - number of transfused units
Arterial injury (dissection, perforation, rupture, surgical conversion, embolization, none)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in procedure plan</measure>
    <time_frame>Within 4 hr. after EVAR procedure rehearsal starts</time_frame>
    <description>Comparison of treatment plans based on Customary (normal institutional) technique, following 3D reconstruction, and after simulation procedures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adjunctive device utilization</measure>
    <time_frame>Within 4 hr. after EVAR procedure ends</time_frame>
    <description>Number and type of used wires, catheters, stent grafts, additional stent graft components and balloons</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gate cannulation time</measure>
    <time_frame>Within 3 hr. after EVAR procedure starts</time_frame>
    <description>Time to cannulate the contralateral gate with a wire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Similarity of simulation to actual case</measure>
    <time_frame>Within 3 hr. after EVAR procedure ends</time_frame>
    <description>Anatomy
Anticipated devices (sizing, tools)
Fluoroscopic Angulations
Case complexity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General satisfaction- Subjective experience of simulation experience</measure>
    <time_frame>Within 4 hr. after EVAR procedure ends</time_frame>
    <description>Overall ease of use
Controls
Imaging
Device exchanges
Device performance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost analysis</measure>
    <time_frame>Within the first 30 days after the EVAR procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical/Clinical success rate</measure>
    <time_frame>Within the first 30 days after the EVAR procedure</time_frame>
    <description>Successful endograft deployment and absence of type 1 or 3 endoleak</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of simulator rehearsal</measure>
    <time_frame>Within 3 hr. after EVAR procedure rehearsal ends</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in ICU</measure>
    <time_frame>within 30 days after the EVAR procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Length of Stay</measure>
    <time_frame>Within 30 days after the EVAR procedure</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Infra Renal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Procedure/Surgery : Endovascular Aneurysm Repair with no prior procedure rehearsal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rehearsal group</arm_group_label>
    <description>Procedure/Surgery : Endovascular Aneurysm Repair with prior procedure rehearsal</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects admitted for elective endovascular AAA repair will be randomized
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. At least 18 years old

          2. Elective patients planned to undergo EVAR procedures with an endograft compatible with
             the Simbionix PRS.

          3. Computed Tomography Angiography (CTA) scan of the abdominal aorta performed as
             standard of care. Sufficient quality/defined protocol.

        Exclusion Criteria:

          1. Subject is below 18 years old

          2. Operator cannot complete the indicated rehearsal and practice.

          3. Patients requiring emergent aneurysm treatment, e.g. trauma or rupture.

          4. Arterial dissection.

          5. Patients with Stage 4 of chronic kidney disease (GFR&lt;30 ml/min/m2).

          6. Patient is indicated for use of snorkels, chimneys, fenestrated or branched graft
             devices

          7. Pregnant or lactating women.

          8. Off label stent graft use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John H. Rundback, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Holy Name Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erez Ben Zvi</last_name>
    <phone>+972 54 669 0924</phone>
    <email>erez.benzvi@3Dsystems.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Baptist Cardiac and Vascular Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barry T Katzen, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Constantino Pena, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Barry T Katzen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Constantino Pena, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida, Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Murray L Shames, MD</last_name>
    </contact>
    <investigator>
      <last_name>Murray L Shames, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holy Name Medical Center</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John H. Rundback, MD</last_name>
      <phone>201-833-7268</phone>
      <email>jrundback@airsllp.com</email>
    </contact>
    <contact_backup>
      <last_name>Ravit Barkama, MD</last_name>
      <phone>201-541-6312</phone>
      <email>barkama@mail.holyname.org</email>
    </contact_backup>
    <investigator>
      <last_name>John H. Rundback, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry R Baele, MD</last_name>
    </contact>
    <investigator>
      <last_name>Henry R Baele, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary M Ansel, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gary M Ansel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>C.H.U De Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicla Settembre, Md</last_name>
    </contact>
    <investigator>
      <last_name>Nicla Settembre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico S. Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauro Gargiulo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mauro Gargiulo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Italy</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2014</study_first_submitted>
  <study_first_submitted_qc>May 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2014</study_first_posted>
  <last_update_submitted>June 16, 2015</last_update_submitted>
  <last_update_submitted_qc>June 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>elective endovascular AAA repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

